Second Edition

Total Page:16

File Type:pdf, Size:1020Kb

Second Edition DIABETES ATLAS SecondSecond edition The mission of the International Diabetes Federation is to work with our member associations to enhance the lives of people with diabetes. Diabetes Atlas committee Bjørnar Allgot (co-chair) Delice Gan (co-chair) Hilary King Pierre Lefèbvre Jean-Claude Mbanya Martin Silink Linda Siminerio Rhys Williams Paul Zimmet Editor and project manager: Delice Gan Project coordinator: Catherine Regniers Diabetes Atlas, second edition, and other IDF publications are available from: International Diabetes Federation Executive Office 19 Avenue Emile de Mot B-1000 Brussels Belgium Tel +32-2-5385511 Fax +32-2-5385114 [email protected] www.idf.org Electronic version of Diabetes Atlas: www.idf.org/e-atlas © International Diabetes Federation, 2003 No part of this publication may be reproduced or transmitted in any form or by any means without the prior written permission of the International Diabetes Federation. First published, 2000 Second edition, 2003 Permission has been obtained to use material from the following organizations: (1) United Nations (2) World Bank (3) World Health Organization Copyright permission has been obtained from Martin Dunitz to adapt ‘The St Vincent Declaration: experience gained for better outcome of cardiovascular, eye and kidney complications in the future’ in Chapter 8. ISBN 2-930229-27-6 Design and layout: perplex | Aalst, Belgium Cover: De Blauwe Peer, Gent, Belgium Printer: Imprimerie L Vanmelle SA, Gent/Mariakerke, Belgium Diabetes Atlas Second Edition Diabetes Atlas Second Edition Acknowledgements The International Diabetes Federation (IDF) Chapter 1 would like to express its thanks to the World 1.1 R Sicree, J Shaw, P Zimmet Diabetes Foundation for its generous support 1.2 R Tapp, J Shaw, P Zimmet in making the Diabetes Atlas, second edition, Chapter 2 possible. 2.1 G Soltèsz, C Patterson, G Dahlquist 2.2 R Singh, J Shaw, P Zimmet IDF would also like to thank Novo Nordisk A/S for its generous support. Chapter 3 Introduction P Zimmet IDF would like to thank Novartis Pharma AG 3.1 N Rigby, RJ Leach, WPT James for its generous support in making possible 3.2 CS Cockram, K Hynes the report on impaired glucose tolerance in Chapter 4 Chapter 1. R Williams IDF would also like to thank Johnson and Chapter 5 Johnson for its generous support in making J-C Mbanya, L Fezeu possible the report on type 2 diabetes in the Chapter 6 young in Chapter 2. 6.1 J Piette 6.2 L Siminerio A publication such as this would not have 6.3 T Songer been possible without the commitment and contribution of many people around the Chapter 7 world. IDF would like to thank and gratefully 7.1 K Ramaiya, R Sicree, C Patterson acknowledges the contributions of the 7.2 M Arab, AS Shera, R Sicree, C Patterson following authors: 7.3 M Massi-Benedetti, L Etu-Seppälä, R Sicree, C Patterson 7.4 Y Vovides, B Wentzell, R Sicree, C Patterson 7.5 A Pérez-Comas, R Sicree, C Patterson 7.6 H Mahtab, MA Sayeed, R Sicree, C Patterson 7.7 G Bunyan, R Sicree, C Patterson Chapter 8 8.1 M Massi-Benedetti, J Akwe Akwi, P Ferolla, MO Federici 8.2 Y Vovides, B Wentzell 8.3 CS Cockram Chapter 9 C Regniers, D Gan, B Allgot Chapter 10 P Lefèbvre Profiles J Colquhoun, D Lukoseviciene, N Ojha, G Rafique, M Silink Appendix 2 A Hornsby Special thanks to S Murray for coordinating the work at the International Diabetes Institute. Diabetes Atlas Second Edition Diabetes Atlas Second Edition IDF also gratefully acknowledges the help of the following people in making this publication possible: N Abdella, K Ajlouni, C Alexander, AS Alkuwari, MC Almaraz, A Al-Nuaim, FI Al-Zurba, T Aspray, V Augustiniene, B Balkau, TK Banerjee, A Barceló, T Beljic, P Bennett, O Bernard, C Berne, PR Betts, G Booth, E Briganti, C Castell, A Chan, S-Y Chen, B Choi, P Chou, LM Chuang, SS Chung, R Colagiuri, S Colagiuri, M Comaschi, D Dabelea, M Dagmar, R Dankner, H Dean, D De Bacquer, B Detournay, CL de Visser, M Dragan, R Duarte, T Dwyer, R Dyck, M Elbagir, M Eliasson, M Engelau, J Eriksson, E Eskelinen, J Feinglass, E Ford, MC Foss, M M-T Fuh, MM Garcia de Belaunde, C Giorda, RT Go, A Goday, R Gupta, CH Han, N Hancu, M Harris, J Harvey, L de Hassine, GE Holder-Nelson, G Hu, C Invitti, ED Janus, J Jervell, F Johansen, AJ Karter, S Kiauka, T Kitagawa, D Koev, M Korecova, CF Kwok, L Lavery, A Lerario, N Levitt, S Likitmaskul, B McBride, M McGill, SM Makled, K Midthjell, J Mohith, Z Naeemullah, P Nilsson, W Nitiyanant, F Nobels, H-H Parving, J Perusicova, G Piatt, E Placzkiewicz, D Ragoobirsingh, A Ramachandran, U Ramdanee, H Rashidi, W Rathmann, I Raz, G Rennert, G Roglic, A Rotchford, E Rudinskiene, M Sadikot, I Satman, MA Sayeed, A Schranz, D Simon, A Sinha, J Skrha, E Spichler, E Stern, S Tandhanand, W Thefeld, R Toomath, J Tuomilehto, G Uwaifo, K Van Acker, D Webb, S Wild, P Wilson, JP Yeo IDF gratefully acknowledges the support and help given by its member associations, task forces and consultative sections. Special thanks to L Al Obaidi, S Ash, V Campanella de Lemes, L Cann, E Ng, N Ohja, P Onraed, L Rabemananjara and Y Vovides for their invaluable contribution in the regions. Diabetes Atlas Second Edition Contents Contents Foreword 7 Introduction 9 Executive Summary 11 1. The Global Burden of Diabetes 15 1.1 Diabetes and Impaired Glucose Tolerance: Prevalence and Projections 17 1.2 Complications of Diabetes 72 2. Diabetes in the Young: a Global Perspective 113 2.1 Global Trends in Childhood Type 1 Diabetes 114 2.2 Type 2 Diabetes in the Young 135 3. The Widening Circle 157 3.1 Obesity 159 3.2 Cardiovascular Disease and Diabetes: Double Jeopardy 167 4. The Economic Impact of Diabetes 175 5. Access to Insulin and Diabetes Supplies 193 6. Diabetes Education 207 6.1 Effectiveness of Self-management Education 208 6.2 Educational Practices: a Global View 216 6.3 Cost-Effectiveness of Diabetes Education 221 7. Meeting the Challenges 225 7.1 Africa 226 7.2 Eastern Mediterranean and Middle East 231 7.3 Europe 237 7.4 North America 244 7.5 South and Central America 250 7.6 South-East Asia 255 7.7 Western Pacific 260 8. Reducing the Burden 267 8.1 The St Vincent Declaration 268 8.2 Declaration of the Americas on Diabetes 276 8.3 Western Pacific Declaration on Diabetes 278 8.4 Declaration of the Eastern Mediterranean and Middle East Region 280 5 Diabetes Atlas Second Edition Contents 9. Diabetes Associations: from Patients to Partners 283 10. Prevention and Strategic Action 301 Appendices Appendix 1 Methodology 305 Appendix 2 Socio-economic Indicators 316 Appendix 3 IDF Member Associations Address List 329 Glossary 345 Acronyms 349 World Diabetes Foundation 352 Index 354 Index of Countries 357 6 Diabetes Atlas Second Edition Foreword Foreword everal years ago it was proposed by my predecessors that it would be helpful to bring together relevant data about diabetes and diabetes associations around Sthe world. This culminated in the publication of the first edition of the Diabetes Atlas at the 17th IDF Congress in Mexico. It was beautifully produced and instantly popular. It went to Ministers of Health in IDF member countries, WHO offices, diabetes associations and many others. The Diabetes Atlas has proved to be an invaluable resource. It was decided that it should go on the IDF website to be updated regularly – but should reappear in hard copy for the 18th IDF Congress in Paris. Many new sections have been included since the first edition. The epidemiology section has been updated, stressing again the rapid rise in prevalence, as has that on economics. A new section on impaired glucose tolerance (IGT) is included, giving an indication of the further rise in diabetes that is to come. This is the first time worldwide data on IGT have been collected together. The prevalence of complications is now included – important for planners, health professionals and people with diabetes alike. It is also the first time that such information has been compiled in one publication. It is useful in showing not only the prevalence data but also the gaps in our knowledge in this area. Another new chapter discusses the relationship between obesity and diabetes as well as the effect of diabetes on cardiovascular disease. The vital topic of access to insulin is also covered – an area of critical importance in many IDF member countries. Diabetes education has an expanded section, emphasizing its role in the successful management of the disease. There are then very useful chapters on IDF regional activities and diabetes associations. Primary prevention and socio-economic indicators complete the text. The evidence that we have shows beyond doubt that diabetes is on an epidemic increase and that the toll from this disease will be huge in economic, social and individual terms if action is not taken now. There is also evidence that prevention of type 2 diabetes is possible. What remains now is for all of us – governments, health organizations, diabetes associations – to take the next step to use the knowledge that we have to curb the rise of diabetes and its complications. 7 Diabetes Atlas Second Edition Foreword I personally feel that the second edition is a major step forward and will prove invaluable to governments and diabetes associations as well as individuals. Production of the Diabetes Atlas is a costly undertaking. We should acknowledge the time given by many colleagues in IDF and also our various sponsors, particularly the new charity the World Diabetes Foundation, without whom the second edition of the Diabetes Atlas would not have been possible.
Recommended publications
  • Annual Review 2007 Table of Contents
    ANNUAL REVIEW 2007 TABLE OF CONTENTS BREAKING THE VICIOUS CIRCLE 4 TOMORROW’S BURDEN, TODAY’S BATTLE 6 Whereas type 1 and 2 diabetes are chronic PLANTING SEEDS FOR LONG TERM CHANGE 8 conditions, gestational diabetes mellitus (GDM) A HOLISTIC APPROACH – A NATIONAL NCD PROGRAMME 10 usually disappears after childbirth. However MAKING A DIFFERENCE IN TANZANIA 12 GDM can have serious consequences for the A CATALYST FOR CHANGE 14 health of the mother and child, both in the short SAVING FEET, SAVING FUTURES 16 and long term. GLOBAL DIABETES WALK 2007 18 The elevated blood glucose levels can affect the child PICTURE GALLERY 20 in the womb by increasing its weight abnormally, PROJECT ACTIVITIES 2007 21 or causing birth defects such as malformations in PREVENTING BLINDNESS IN RURAL INDIA 26 fingers and toes and can affect the heart and brain. SCREENING FOR DIABETES IN INDIA 28 In the state of Tamil Nadu COST EFFECTIVE PREVENTION OF DIABETES 30 in India, 10% of all 1.5 million annual pregnancies SUSTAINING HOPE FOR FUTURE GENERATIONS 32 end as miscarriages. The stillbirth rate is 14 per PRIMARY PREVENTION IN INDIAN SCHOOLS 34 1000 live births, covering all causes. It is estimated FIGHTING OBESITY AND ITS COMPLICATIONS IN CHINA 36 that 15% of the total number of caesarean sections may DIABETES SUMMIT AFRICA, KENYA 2007 38 be due to GDM. HIGH NOTES FOR A SERIOUS CAUSE 40 GDM is one of the focus areas of the ANNUAL ACCOUNTS 2007 42 World Diabetes Foundation. BREAKING THE VICIOUS CIRCLE Chronic diseases and poverty are interconnected in a vicious circle; as in almost all countries, the poorest people are the ones most at risk of developing chronic diseases and dying prematurely from the severe complications, or suffering long term from the associated morbidity.
    [Show full text]
  • Department of Physiology Tirunelveli Medical College Tirunelveli – 627 011
    A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS Dissertation submitted to THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY, CHENNAI – 600 032 In partial fulfillment of the requirement for the degree of Doctor of Medicine in Physiology (Branch V) M.D. (PHYSIOLOGY) APRIL – 2017 DEPARTMENT OF PHYSIOLOGY TIRUNELVELI MEDICAL COLLEGE TIRUNELVELI – 627 011. CERTIFICATE This is to certify that the dissertation entitled, “A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS” by Dr. SUJATHA ANDREW, postgraduate in PHYSIOLOGY (2014-2017), is a bonafide research work carried out under our direct supervision and guidance and is submitted to The Tamilnadu Dr.M.G.R. Medical University, Chennai, for M.D., Degree Examination in Physiology (Branch V), to be held in April 2017. Dr. Ratna Manjushree Jayaraman M.D.,D.C.H., Dr.K. Sithy Athiya Munavarah, M.D., Associate Professor and Head , Dean, Department of Physiology, Tirunelveli Medical College, Tirunelveli Medical College, Tirunelveli – 11. Tirunelveli - 11. ENDORSEMENT BY THE GUIDE This is to certify that the dissertation entitled, “A CROSS SECTIONAL STUDY TO CORRELATE THE DURATION OF DIABETES, GLYCEMIC CONTROL, AUTONOMIC NEUROPATHY AND DERMATOLOGICAL MANIFESTATIONS IN TYPE 2 DIABETES MELLITUS’’ is a bonafide research work carried out by Dr. SUJATHA ANDREW in the Department of Physiology, Tirunelveli Medical College & Hospital, Tirunelveli – 11 under my direct guidance and supervision in partial fulfillment of the requirement for the award of the degree of M.D., in PHYSIOLOGY (Branch – V) in April 2017.
    [Show full text]
  • TYPE 1 DIABETES a Very Special Issue 47
    E U ISS GLOBAL PERSPECTIVES ON DIABETES Volume 56 – D ecember 2011 SPECIAL TYPE 1 DIABETES A very special issue 47 6 32 DiabetesVoice 43 CONTENTS DIABETES VIEWS 4 International Diabetes Federation Promoting diabetes care, prevention and a cure worldwide THE GLOBAL IMPACT Diabetes Voice is published quarterly and is freely available Estimating the worldwide burden of type 1 diabetes 6 Leonor Guariguata online at www.diabetesvoice.org. Hope springs for young people with type 1 diabetes 9 The production of this Special Issue has been made possible Graham Ogle and Larry Deeb thanks to the support of Sanofi Diabetes. The 3-C Study – strong partnerships to improve care This publication is also available in French, Spanish for people with type 1 diabetes in China 13 and Chinese. Linong Ji and Helen McGuire Editor-in-Chief: Stephanie A Amiel, UK MANAGEMENT, CARE AND PREVENTION Managing Editor: Olivier Jacqmain, [email protected] The key to managing diabetes without tears – the treatment and Editor: Tim Nolan, [email protected] Advisory group: Pablo Aschner (Colombia), teaching programme for flexible insulin therapy in Germany 16 Ruth Colagiuri (Australia), Patricia Fokumlah (Cameroon), Ulrich Alfons Müller Attila József (Hungary), Viswanathan Mohan (India). Taking the benefits of DAFNE to the UK and beyond 19 Layout and printing: Luc Vandensteene, Ex Nihilo, Belgium, Stephanie A Amiel, Julia Lawton, Simon Heller www.exnihilo.be Positive results in Australia – OzDAFNE takes up the challenge 22 All correspondence and advertising enquiries should be Dianne Harvey addressed to the Managing Editor: Never say never – implementing DAFNE in Kuwait 24 International Diabetes Federation, Chaussée de La Hulpe 166, Ebaa Alozairi 1170 Brussels, Belgium Phone: +32-2-5431626 – Fax: +32-2-5385114 – [email protected] Great results for DAFNE Singapore – next stop, South-East Asia 27 Su-Yen Goh and Daphne Gardner Making progress with immune therapies for type 1 diabetes 29 © International Diabetes Federation, 2010 – All rights reserved.
    [Show full text]
  • Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign
    November 3, 2008 Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign BEDFORD, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the global leader in patch pump technology, and the International Diabetes Federation (IDF) today announced that Insulet is an official partner of IDF's World Diabetes Day (WDD) campaign. World Diabetes Day, celebrated on November 14, will raise awareness of children and adolescents with diabetes, spotlighting both the impact of the disease and access to care. "Insulet's mission is to improve the lives of people with diabetes, so we felt it was imperative to join IDF to increase global awareness of this devastating disease, which affects millions of people worldwide," said Duane DeSisto, Insulet's president & chief executive officer. "Our easy-to-use OmniPod® Insulin Management System helps people with diabetes stay healthy while living life fully. OmniPod's innovative, tubing-free design provides all the benefits of pump therapy, which supplies the best control over diabetes, while eliminating the hassles of a traditional pump. Its virtually pain-free automated insertion has no needles in sight, which appeals to both children and adults. But primarily, OmniPod enables people with diabetes to simply live their lives normally." The campaign also emphasizes that, with the right treatment, children and adolescents can live full, healthy and productive lives. To ensure this, it's vital that parents know the early warning signs of diabetes and if their child shows these signs, to seek immediate medical attention. These signs include: -- Frequent urination -- Excessive thirst -- Increased hunger -- Rapid weight loss -- Tiredness -- Lack of interest and concentration -- Blurred vision -- Vomiting and stomach pain (often mistaken as the flu) "We are extremely pleased that Insulet is an official partner in World Diabetes Day and very much welcome their support and expertise in diabetes to bring attention to the disease," said World Diabetes Day Campaign Director Phil Riley.
    [Show full text]
  • World Diabetes Day – November 14, 2020
    World Diabetes Day – November 14, 2020 SATNOV 14 WHAT IS WORLD DIABETES DAY? World Diabetes Day is every year on November 14, first created in 1991 by the International Diabetes Foundation and the World Health Organization. Diabetes is a chronic disease where the pancreas doesn’t produce enough insulin if any at all. It also leads to serious health conditions and, in many ways, can be preventable. That’s why we take this day to spread awareness and education. HISTORY OF WORLD DIABETES DAY Diabetes is considered to have been around 1550 BC. The successful extraction and injection of insulin into humans was discovered in 1922. So, comparatively, our understanding of diabetes is quite new compared to its long, arduous march through history. The difference between type two and type one started around 1850, where medical professionals at the time believed that they knew enough of the difference between the two to warrant two categories. Since then, type II diabetes has ballooned to 90 percent of the those affected, with an estimated $425 million individuals affected worldwide. This alarming rise in such a preventable disease is one of the reasons the WHO and IDF wanted to create World Diabetes Day – to help spread awareness of how to prevent contracting the illness. Having to manage blood sugar levels on a daily basis is a time-consuming and costly endeavor, as the economic cost of diabetes globally is around $727 billion (USD) and in the US alone it costs almost a third of that, at $245 billion. The costliness and its prevention create even more reason for us to spread awareness of the disease, and also celebrate the birth of the man who helped bring insulin into the modern world as an effective treatment against it.
    [Show full text]
  • BAOJ Diabetes Edson Da Silva, BAOJ Diabet 2017, 3: 2 3: 023
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/317003906 World Diabetes Day Article · May 2017 CITATIONS READS 0 592 1 author: Edson Da Silva Federal University of Jequitinhonha and Mucuri Valleys 84 PUBLICATIONS 140 CITATIONS SEE PROFILE All content following this page was uploaded by Edson Da Silva on 03 September 2020. The user has requested enhancement of the downloaded file. BAOJ Diabetes Edson da Silva, BAOJ Diabet 2017, 3: 2 3: 023 Editorial World Diabetes Day *Edson da Silva Group of Studies and Research on Diabetes, Department of Basic Sciences, Federal University of Jequitinhonha and Mucuri Valleys, Brazil Editorial Article disadvantaged and vulnerable, and children/teenagers with or at risk for DM [4,5]. In 2014-2015, ‘Healthy Living and Diabetes’ was World Diabetes Day (WDD) is celebrated every year on November the theme of WDD. The theme for 2016 ‘Eyes on Diabetes’ focused 14. WDD was created in 1991 by IDF and the World Health on the importance of early screening for diabetes [2]. Organization (WHO) in response to the rapid rise of diabetes mellitus (DM) in the world [1]. Since 2006 the WDD became an The WDD campaign is represented by an IDF’s blue circle logo official United Nations Day with the passage of United Nation that was adopted in 2007 after the passage of the United Nation Resolution 61/225 [2]. Resolution on diabetes. The blue circle is the global symbol for diabetes awareness. It signifies the unity of the global diabetes November 14th was chosen as WDD because it is the birthday of community in response to the diabetes epidemic.
    [Show full text]
  • November 2020 Lion John Mason, District Governor
    November 2020 Lion John Mason, District Governor In a world where you can be anything, be kind. We had a successful Fall Conference despite COVID-19. We had Lions throughout our district and state to participate in an unusual conference. I want to THANK YOU for attending and braving the fall weather. In just a couple of weeks, we will be celebrating Thanksgiving. Please be careful and follow COVID-19 guidelines such as wearing a mask and social distancing. Please remember we have a lot to be thankful for, more than some. If you are able to, please help someone less fortunate in your community. Our clubs need to continue to SERVE. Membership Update-District 29 I has added 56 new members. The LEAD by EXAMPLE challenge has seen PCC Cindy Glass, Lion Mickey Nardella, and Lion Kermit Hawley accept the challenge to bring in a new member. Also, NAMI contest update: the individual leader with 10 new members is Patricia Sewell and in second is Cheryl Roberts with 9 new members. The Club leader with 14 new members in Martinsburg Centennial and Shepherdstown Centennial is close behind with 10 new members It is time to make plans for the upcoming 2021 Lions of West Virginia Leadership Retreat to be held January 29-30 at the Days Inn, Flatwoods, WV. Registration form and scholarship applications are available in the newsletter. “Being a Lion isn’t about doing the same thing year after year in the name of tradition. Being a Lion means looking for how you can best be of service.
    [Show full text]
  • A Systematic Review of the Prevalence and Treatment of Type 2 Diabetes in Nigeria
    www.idosr.org Offu ©IDOSR PUBLICATIONS International Digital Organization for Scientific Research ISSN: 2579-0730 IDOSR JOURNAL OF BIOLOGY, CHEMISTRY AND PHARMACY 3(1) 124-146, 2019. A Systematic Review of the Prevalence and Treatment of Type 2 Diabetes in Nigeria. Ogochukwu Fidelia Offu Department of Clinical Pharmacy and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Enugu State University of Science and Technology, Agbani, Enugu State, Nigeria. Email: [email protected] ABSTRACT Diabetes is on the increase in Nigeria and previous systematic reviews and meta- analysis have reported estimates of the prevalence of Type 2 Diabetes Mellitus in Nigeria. However, because of differences in population characteristics, these estimates will vary across and within geopolitical zones. Despite the increase in prevalence of Type 2 Diabetes Mellitus in the country, no other systematic review has been carried out to assess diabetes treatment pattern in Nigeria. Hence, the importance of this study, as it critically reviews the disease prevalence and treatment pattern across and within geopolitical zones in Nigeria.To systematically review all prevalence and treatment studies published from January, 1998 to September, 2018. The following databases were searched for articles: PubMed Central (PMC), African Journal On Line (AJOL), Science Direct, and Connecting Repositories (CORE). Google scholar was also searched. 159 articles were identified from the databases while 12 were identified from Google Scholar. Studies that were excluded are: Studies that dealt mainly the prevalence of Type 1 Diabetes Melitus/gestational diabetes (14); studies with self reported diagnosis (12); case reports and editorials (10); studies that were not representative of the general population (7); and studies without case definitions (8) were excluded from the pool of studies to obtain 38 studies that were utilized for the review.
    [Show full text]
  • World Diabetes Day Take Place? Professionals, Healthcare Authorities, and Individuals Who Want to Make a Difference
    nfic[[`XY\k\j[Xp (+Efm\dY\i www.worlddiabetesday.org A campaign led by the International Diabetes Federation The premier awareness campaign of the diabetes world When does World Diabetes Day take place? professionals, healthcare authorities, and individuals who want to make a difference. World Diabetes Day takes place on 14 World Diabetes Day unites the global diabetes November every year. The date was chosen community to produce a powerful voice for because it marks the birthday of Frederick diabetes awareness. Banting, who, along with Charles Best, is credited with the discovery of insulin. While many events How is it marked? take place on or around the day itself, a themed campaign runs throughout the year. IDF member associations and partners develop an extensive range of activities, tailored to a variety How did it all begin? of groups. Activities that are organized every year include: World Diabetes Day was introduced by the International Diabetes Federation (IDF) and the World • Walks and cycle rides Health Organization (WHO) in 1991, in response to • Radio and television programmes concern over the escalating incidence of diabetes • Sports events around the world. Since then, the event has grown in • Free screenings for diabetes and its complications popularity every year. • Public information meetings • Poster and leaflet campaigns Where does it take place? • Diabetes workshops and exhibitions • Press conferences World Diabetes Day is celebrated worldwide. It brings • Newspaper and magazine articles together millions of people in over 160 countries to • Events for children and adolescents raise awareness of diabetes, including children and adults affected by diabetes, healthcare professionals, For further information see section entitled healthcare decision-makers and the media.
    [Show full text]
  • Bring Diabetes to Light Challenge
    World Diabetes Day – International Diabetes Federation Bring Diabetes to Light Challenge Page 1 of 24 World Diabetes Day – International Diabetes Federation Dear Colleagues and friends This document has been developed to provide guidance and resources to help you plan and communicate activities surrounding the lighting of iconic monuments to mark World Diabetes Day 2009. Last year saw the first 'Monumental Challenge'. The response was truly amazing, exceeding all expectations. A total of 1107 iconic sites and buildings lit the World Diabetes Day skyline. The participating icons were joined by many more lightings of office buildings and individual homes. We would like to thank everyone involved for their hard work in making last year’s World Diabetes Day 2008 such a tremendous success. This document provides core materials and step-by-step recommendations to help you with the planning, execution and promotion of your landmark illumination. We hope that a coordinated approach will facilitate a unified global campaign across all regions. We hope that this document provides you with all the necessary materials to ensure a successful event in your country. If you have any questions, please do not hesitate to contact World Diabetes Day team members Dominique Robert – [email protected] (+32-2-5431630) (English and French) or Merry Rivas – [email protected] (Spanish). Over recent years the global diabetes community has made remarkable steps towards increasing awareness of diabetes, but we still have a long way to go if we are to attract the attention and funding that the communicable diseases receive. Together, we persuaded the United Nations to recognize World Diabetes Day as an official UN health day and pass a World Diabetes Day Resolution (61/225).
    [Show full text]
  • WORLD DIABETES DAY 2016 ISSUE EYES on DIABETES Over 400 Million People Currently Live with Diabetes
    Diabetes Voice GLOBAL PERSPECTIVES ON DIABETES Issue 4 November 2016 WORLD DIABETES DAY 2016 ISSUE EYES ON DIABETES Over 400 million people currently live with diabetes. One in two is undiagnosed. Screening for type 2 diabetes is important to ensure early diagnosis and treatment to reduce the risk of serious complications. ACT TODAY TO CHANGE TOMORROW www.worlddiabetesday.org CONTENTS 13 THE GLOBAL CAMPAIGN 18 THE GLOBAL CAMPAIGN Why screen for type 2 diabetes? Diabetic retinopathy: from evidence and promise to real life obser vations 4 DIABETES VIEWS 13 Why screen for type 2 diabetes? Welcome to the World Diabetes Day David Cavan 2016 Special Edition Douglas Villarroel 18 Diabetic retinopathy: from evidence and THE GLOBAL CAMPAIGN promise to real life observations 6 WDD 2016 around the world Sehnaz Karadeniz 23 Regional report: racing to Beat Diabetes in 10 IDF School of Diabetes: Tackling Brazil diabetes through education Maria Tereza B. Lima EYES ON International Diabetes Federation © International Diabetes Federation, 2016 - All rights reserved. No part Promoting diabetes care, prevention and a cure worldwide of this publication may be reproduced or transmitted in any form or by Editor-in-Chief: Douglas Villarroel any means without the written prior permission of the International DIABETES Editor: Elizabeth Snouffer Diabetes Federation (IDF). Requests to reproduce or translate IDF Over 400 million people currently live with diabetes. Editorial Coordinator: Lorenzo Piemonte publications should be addressed to [email protected]. One in two is undiagnosed. All correspondence should be addressed to: The material in this document is for information purposes only. IDF makes no representation or warrantires about the accuracy and reli- Screening for type 2 diabetes is important to ensure Elizabeth Snouffer, Editor International Diabetes Federation ability of any content in the document.
    [Show full text]
  • (WDD) World Diabetes
    WORLD DIABETES DAY - DIABETESDAY World Diabetes Day (WDD) World Diabetes Day (WDD) is announced by the International Diabetes Federation (IDF) and the World Health Organization (WHO) jointly. The basis for this focus is the growing menace of the diabetes epidemic in global proportions. WDD became a official United Nations Day in 2006 while first WDD was celebrated in 1991. The day of the year is usually taken as 14 th of November every year. The reason being that November 14 th is the birthday of the Sir Frederick Banting who is the co- discoverer of insulin with Charles Best. WDD is the most expansive awareness program at a global level. It is estimated to reach over a 1 billion people in more than 160 countries. It is anticipated that this will keep the awareness of the menacing epidemic of diabetes in the public and political mindset. The Objectives of the World Diabetes Day are : Promote IDF advocacy efforts throughout the year. To be the global driver to promote the importance of taking coordinated and concerted actions to confront diabetes as a critical global health issue. The official logo is a blue circle which was adopted in 2007. It is the symbol of awareness of diabetes globally. It also underlines the unity of purpose of the global diabetes community facing the diabetic epidemic. Annually the World Diabetes Day campaign focuses on a dedicated theme that runs for one or more years. The theme for World Diabetes Day 2018-19 is Family and Diabetes. Past campaigns: World Diabetes Day 2017: Women and Diabetes WHY FAMILY AND DIABETES A two-year time frame has been chosen to best facilitate planning, development, promotion and participation.
    [Show full text]